Cheat sheet

ANCC PMH-BC Cheat Sheet

Practice this exam

Assessment and Diagnosis

  • 22% of exam
  • Developmental Stages Physiologic Mimics DSM-5-TR Categories Defense Mechanisms MSE + Risk Tools

Planning

  • 21% of exam
  • Client-Centered Care Cultural Competence Communication Barriers Treatment Planning SMART Goals

Implementation

  • 46% of exam
  • Treatment Modalities Psychopharmacology Milieu Management Therapeutic Communication Crisis Intervention Neurostimulation

Evaluation

  • 10% of exam
  • Legal + Ethical Outcome Measurement Process Improvement Confidentiality

Quick Facts

  • Exam PMH-BC
  • Credential Body ANCC
  • Level RN (not NP)
  • Questions 150 (125 scored + 25 pretest)
  • Time 3 hours
  • Pass Scaled 350/500
  • Validity 5 years
  • Eligibility 2yrs RN, 2000hrs psych, 30hrs CE
  • Fee $395 (non-member)

SIG E CAPS (Depression Symptoms) AS

  • Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicidality
  • S: Sleep change I: Interest loss G: Guilt/worthlessness E: Energy loss C: Concentration A: Appetite change P: Psychomotor change S: Suicidal ideation

Delirium vs Dementia AS

Delirium

  • Acute onset, hours to days
  • Fluctuating attention/awareness
  • Often reversible medical cause

Dementia

  • Gradual onset, months to years
  • Stable attention, progressive memory loss
  • Usually irreversible/degenerative
  • Sudden-fluctuating vs slow-progressive

Suicide Risk -> Intervention Level AS

  • Vague ideation, no plan-or-means, protective factors → Outpatient safety plan + close follow-up
  • Plan, no access to means; ambivalent → Raise care level, remove means, safety-contract
  • Specific plan, access to means, clear-intent → 1:1 observation + immediate psychiatric evaluation
  • Attempt in progress or just occurred → Emergency medical stabilization first ( Then psychiatric evaluation )
  • Command hallucinations to harm self → Treat as high risk ( Regardless of stated intent )
  • Chronic risk factors, no acute ideation → Ongoing risk monitoring + safety planning
  • Meets danger criteria, refuses voluntary care → Initiate involuntary commitment ( Per state law )

DSM-5-TR Mood Disorders AS

  • MDD ≥5 Sx, ≥2wks, mood-or-anhedonia
  • Bipolar I Full manic episode, 7+ days
  • Bipolar II Hypomania + MDE, no full mania
  • Cyclothymic D/O 2+ yrs subthreshold highs/lows
  • Persistent Depressive D/O Depressed mood most days, 2+ yrs Dysthymia
  • PMDD Mood symptoms tied to luteal phase

DIGFAST (Mania Symptoms) AS

  • Distractibility, Indiscretion, Grandiosity, Flight-of-ideas, Activity increase, Sleep deficit, Talkativeness
  • D: Distractibility I: Indiscretion G: Grandiosity F: Flight of ideas A: Activity increase S: Sleep deficit T: Talkativeness

Bipolar I vs Bipolar II AS

Bipolar I

  • Full manic episode, 7+ days
  • Hospitalization can define episode
  • Depressive episode not required for diagnosis

Bipolar II

  • Hypomanic episode, 4+ days
  • Requires 1+ major depressive episode
  • No history of full mania
  • Mania present vs mania absent

DSM-5-TR Anxiety and Trauma Disorders AS

  • GAD Excessive worry, 6+ months, multi-domain
  • Panic Disorder Recurrent unexpected attacks + 1mo worry
  • Social Anxiety D/O Fear of social-performance situations, ≥6mo
  • Specific Phobia Marked fear of object-situation, ≥6mo
  • PTSD Symptoms 1+ month after trauma exposure
  • Acute Stress D/O Symptoms 3 days-1 month post-trauma
  • OCD Obsessions-compulsions, ≥1hr-day or distress

CAGE (Alcohol Use Screening) AS

  • Cut-down, Annoyed, Guilty, Eye-opener; 2+ yes screens positive
  • C: Cut down attempts A: Annoyed by criticism G: Guilty about drinking E: Eye-opener drink

Positive vs Negative Symptoms AS

Positive

  • Hallucinations
  • Delusions
  • Disorganized speech/behavior

Negative

  • Flat affect
  • Avolition/anhedonia
  • Alogia, social withdrawal
  • Added experiences vs lost functions

Personality Disorders AS

  • Cluster A Odd/eccentric Paranoid, Schizoid, Schizotypal
  • Cluster B Dramatic/erratic Antisocial, Borderline, Histrionic, Narcissistic
  • Cluster C Anxious/fearful Avoidant, Dependent, OCPD
  • Borderline PD Unstable relationships/self-image, splitting, self-harm
  • Antisocial PD Disregard, deceit, no remorse, conduct-before-15
  • Narcissistic PD Grandiosity, need for admiration, low empathy
  • Histrionic PD Excessive emotionality, attention-seeking
  • Avoidant PD Social inhibition, inadequacy, criticism-sensitive

Borderline PD vs Antisocial PD AS

Borderline

  • Unstable relationships/self-image
  • Fear of abandonment, splitting
  • Self-harm/suicidal gestures common

Antisocial

  • Disregard for others' rights
  • Deceit, lack of remorse
  • Conduct disorder before age 15 required
  • Fears-abandonment vs disregards-others

Substance Use and Withdrawal AS

  • Alcohol Withdrawal Onset 6-24h: tremor, anxiety, tachycardia
  • CIWA-Ar Standardized alcohol withdrawal severity scale
  • Delirium Tremens Peaks 48-96h, autonomic instability, hallucinations, emergency
  • Opioid Withdrawal Flu-like, not life-threatening
  • Benzo Withdrawal Seizure risk; taper, don't stop abruptly
  • Wernicke-Korsakoff Confusion-ataxia-ophthalmoplegia triad; give thiamine first

Defense Mechanisms AS

  • Denial Refusing to acknowledge reality
  • Projection Attributing own feelings to others
  • Rationalization Logical excuse for unacceptable behavior
  • Displacement Redirecting feelings to a safer target
  • Regression Reverting to earlier developmental behavior
  • Reaction Formation Opposite behavior to unacceptable impulse
  • Sublimation Channeling impulse into productive activity
  • Splitting All-good or all-bad thinking, no gray

Therapeutic Communication Techniques PL

  • Active Listening Full attention, verbal + nonverbal cues
  • Open-Ended Questions Encourage elaboration, not yes/no
  • Reflection Mirror feeling back to client
  • Restating Repeat main idea in own words
  • Clarification Check understanding of a vague statement
  • Broad Openings Invite client to choose topic
  • Silence Allow processing time, show patience
  • Summarizing Review key points near session end

NMS vs Serotonin Syndrome IM

NMS

  • Antipsychotic (D2 blockade) cause
  • Slow onset over days
  • Lead-pipe rigidity + hyporeflexia

Serotonin Syndrome

  • Serotonergic drug combo cause
  • Rapid onset, under 24h
  • Hyperreflexia + clonus
  • Rigid-and-slow vs hyperreflexic-and-fast

Adverse Reaction -> Drug Class / Syndrome IM

  • Rapid onset, hyperreflexia, clonus, agitation, diarrhea → Serotonin syndrome ( Stop serotonergic agents; supportive care )
  • Slow onset, lead-pipe rigidity, hyperthermia, dysautonomia → Neuroleptic malignant syndrome (NMS) ( Stop antipsychotic; check CK )
  • Tremor, ataxia, confusion, GI-upset on lithium → Lithium toxicity ( Check level, hold dose, hydrate )
  • Subjective restlessness, pacing, can't sit still → Akathisia ( May mimic worsening anxiety )
  • Sudden muscle spasm, torticollis, oculogyric crisis → Acute dystonia ( IM benztropine or diphenhydramine )
  • Shuffling gait, tremor, rigidity, mask-like face → Pseudoparkinsonism ( Anticholinergic or dose reduction )
  • Fever, sore throat, low WBC on-clozapine → Agranulocytosis ( Stop drug; hematology consult )
  • Repetitive lip-smacking-tongue movement, long-term antipsychotic → Tardive dyskinesia ( May be irreversible; consider switch )

Antidepressants: SSRIs and SNRIs IM

  • SSRIs First-line; 4-6 wk onset fluoxetine, sertraline, escitalopram
  • SNRIs Dual reuptake; may raise BP venlafaxine, duloxetine
  • Common Side Effects GI upset, sexual dysfunction, insomnia
  • Black Box Warning Increased suicidality risk under age 25
  • Discontinuation Syndrome Flu-like, dizzy, 'brain zaps' if abrupt-stop
  • Serotonin Syndrome Risk Danger combining w/ MAOIs, triptans, tramadol

Typical vs Atypical Antipsychotics IM

Typical

  • D2 blockade only
  • High EPS/TD risk
  • e.g. haloperidol, chlorpromazine

Atypical

  • D2 + 5-HT2A blockade
  • Lower EPS, higher metabolic risk
  • e.g. risperidone, olanzapine, clozapine
  • EPS risk vs metabolic risk

Antipsychotics: Typical and Atypical IM

  • Typical (1st-gen) D2 blockade, high EPS/TD risk haloperidol, chlorpromazine
  • Atypical (2nd-gen) D2 + 5-HT2A, lower EPS, metabolic risk risperidone, olanzapine, quetiapine, aripiprazole
  • Clozapine Treatment-resistant; requires ANC monitoring
  • Metabolic Syndrome Weight gain, dyslipidemia, hyperglycemia risk
  • LAI/Depot Long-acting injectable improves adherence
  • EPS Risk Hierarchy High-potency-typicals highest, atypicals lowest except-risperidone
  • Prolactin Elevation Risperidone notably raises prolactin

Mood Stabilizers IM

  • Lithium Therapeutic 0.6-1.2 mEq/L (maintenance ~0.6-1.0)
  • Lithium Toxic >1.5; severe >2.0 mEq/L
  • Lithium Monitoring Trough 12h post-dose; renal + thyroid function
  • Valproic Acid 50-125 mcg/mL; hepatotoxic, teratogenic
  • Carbamazepine Agranulocytosis/aplastic anemia risk; monitor CBC
  • Lamotrigine Slow titration; Stevens-Johnson syndrome risk

Benzodiazepines and Anxiolytics IM

  • Benzodiazepines Short-term anxiety/agitation, dependence risk lorazepam, diazepam, alprazolam
  • Buspirone Non-benzo; onset 2-4wks, no PRN
  • Flumazenil Benzodiazepine antagonist/reversal agent
  • Respiratory Depression Risk Danger combining benzos w/ opioids/alcohol
  • Long-Term Use Tolerance-withdrawal risk; taper, don't stop-abruptly

Psychiatric Emergency Syndromes IM

  • Serotonin Syndrome Rapid onset, hyperreflexia/clonus, hyperthermia
  • NMS Slow onset, lead-pipe rigidity, autonomic instability
  • Acute Dystonia Sudden spasm, torticollis; give IM anticholinergic
  • Akathisia Subjective/observed motor restlessness
  • Tardive Dyskinesia Involuntary orofacial movements; may be irreversible
  • Anticholinergic Toxicity Confusion, dry mucosa, urinary retention
  • Clozapine Agranulocytosis ANC under 500; fever-sore-throat warns

Therapeutic Modalities IM

  • CBT Restructure distorted thoughts, present-focused
  • DBT Emotion-regulation + distress-tolerance; built for BPD
  • Milieu Therapy Structured, safe therapeutic environment
  • ECT Severe-treatment-resistant depression; main effect memory-loss
  • TMS Noninvasive neurostimulation, no anesthesia
  • Motivational Interviewing Client-centered, resolves ambivalence
  • Trauma-Informed Care Recognize trauma, avoid re-traumatization

SAD PERSONS (Suicide Risk Factors) EV

  • Checklist of risk factors that raise suicide concern
  • S: Sex (male) A: Age (young or old) D: Depression P: Previous attempt E: Ethanol/substance use R: Rational thought loss S: Social support lack O: Organized plan N: No spouse S: Sickness

Legal/Ethical Trigger -> Correct Action EV

  • Patient threatens an identifiable third party → Duty to warn/protect (Tarasoff) ( Notify victim or law-enforcement per-state )
  • Patient lacks capacity, refuses emergency care → Use emergency-implied consent for imminent danger
  • Escalating/aggressive behavior, other options exhausted → Least restrictive intervention first ( De-escalate before restraint/seclusion )
  • Restraint or seclusion in use → Time-limited order + continuous monitoring ( Document per policy )
  • Third party requests medical record disclosure → Verify signed release before disclosing ( Confidentiality/HIPAA )
  • Suspected documentation/safety error observed → Report through incident/quality process ( Process improvement )

Legal and Ethical Principles EV

  • Informed Consent Voluntary, competent, informed of risks/benefits
  • Confidentiality HIPAA-protected; exceptions incl. duty to warn
  • Duty to Warn Notify identifiable victim of credible threat Tarasoff
  • Involuntary Commitment Danger to self-others or grave disability
  • Least Restrictive Environment Use least restrictive intervention necessary
  • Restraint/Seclusion Time-limited order, continuous monitoring, last resort
  • Capacity vs Competency Capacity = clinical/situational; competency = legal
  • Advance Psychiatric Directive Documents future mental health treatment preferences

Common Traps

Onset speed trap

  • Serotonin syndrome develops fast, under 24h ≠ NMS develops slowly, over days

Therapeutic level does not mean safe

  • Normal lithium level still toxic-if-dehydrated ≠ Assess symptoms, not just the number

EPS isn't typical-only

  • Atypicals cause EPS too, especially-risperidone high-dose ≠ Don't rule out EPS for atypicals

Duty to warn is not blanket disclosure

  • Applies to specific, identifiable, credible threats ≠ Routine records still need consent-to-release

Pretest questions are invisible

  • 25 of 150 questions are unscored-pretest ≠ Cannot be identified during exam; answer-all

Bipolar II is not 'mild bipolar I'

  • Bipolar II requires a major-depressive episode ≠ Full mania reclassifies it as Bipolar-I

Capacity vs competency confusion

  • Capacity is a clinical, situational judgment ≠ Competency is a court's legal determination

Last Minute

  • 1. 22-21-46-10: Assess-Plan-Implement-Eval weight order
  • 2. 150 total, 125 scored, 25 pretest
  • 3. 3-hour limit; passing 350-of-500 scaled-score
  • 4. Lithium 0.6-1.2 mEq-L; toxic above 1.5
  • 5. Serotonin-syndrome fast-onset-hyperreflexia; NMS slow-onset-rigidity
  • 6. Clozapine: ANC monitoring; agranulocytosis under 500
  • 7. Bipolar-I needs mania; Bipolar-II needs hypomania-MDE
  • 8. Tarasoff: warn identifiable, credible victim threats
  • 9. Use least-restrictive intervention before restraint-seclusion
  • 10. PMH-BC is RN-level; PMHNP-BC is advanced-practice
  • 11. Valid 5yrs; needs 2yrs-RN, 2000hrs-psych, 30CE

PMH-BC Psychiatric-Mental Health Nursing

  • Practice Questions 100 questions Study Guide 32 topics Cheat Sheet 89 facts Flashcards 50 cards Blogs 2 blogs Free CE Podcast